Evidence map›Paper›PMID 26990629›Full record

Observational studyAIDS (London, England)2016

Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.

Meghan E Fitzpatrick, Mehdi Nouraie, Matthew R Gingo, Danielle Camp, Cathy J Kessinger, James B Sincebaugh, Andrew Clarke, John W Ries, Eric C Kleerup, Lawrence Kingsley and 1 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in AIDS (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Identifying Metabolomic Biomarkers of Lung Function Decline in People with HIV.Journal of acquired immune deficiency syndromes (1999) · 2025
    Article
  4. Review
  5. HIV-associated lung disease.Nature reviews. Disease primers · 2023
    Review
  6. Article
  7. Article
  8. COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.International journal of chronic obstructive pulmonary disease · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. World AIDS Day: 40 years of an evolving pulmonary landscape.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  13. Observational
  14. Article
  15. Article
  16. Chronic obstructive pulmonary disease in HIV.Expert review of respiratory medicine · 2021
    Review
  17. Article
  18. Lung function in men with and without HIV.AIDS (London, England) · 2020
    Observational
  19. Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function.American journal of respiratory and critical care medicine · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Meghan E FitzpatrickaDepartment of Medicine, University of Pittsburgh, Pittsburgh bDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California cDepartment of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh dDepartment of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Mehdi Nouraie
Matthew R Gingo
Danielle Camp
Cathy J Kessinger
James B Sincebaugh
Andrew Clarke
John W Ries
Eric C Kleerup
Lawrence Kingsley
Alison Morris
University of Pittsburgh · US

Funding

Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLADWIN, MARK T · 2011 to 2020
$26.1M
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV CohortR01HL090339 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORRIS, ALISON · 2007 to 2011
$4.0M
Translational evaluation of aging, inflammation, and HIV in lung dysfunctionR01HL120398 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORRIS, ALISON · 2013 to 2017
$3.4M
Longitudinal evaluation of HIV-associated lung disease phenotypesR01HL125049 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MELLORS, JOHN W, MORRIS, ALISON · 2014 to 2017
$3.3M
Mentoring and Patient-Oriented Research in HIV Obstructive Lung DiseaseK24HL123342 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORRIS, ALISON · 2014 to 2018
$571k
Role of Systemic and Pulmonary Immune Aging in HIV-associated COPDF32HL114426 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FITZPATRICK, MEGHAN E · 2012 to 2013
$126k
NHLBI NIH HHS F32 HL114426NHLBI NIH HHS K24 HL123342NHLBI NIH HHS P01 HL103455NHLBI NIH HHS R01 HL090339NHLBI NIH HHS R01 HL120398NHLBI NIH HHS R01 HL125049
6 · The paper itself

Abstract

objectiveChronic obstructive pulmonary disease is a common comorbidity in HIV, with prevalence and severity of disease incompletely explained by risk factors such as smoking and age. Unique HIV-associated factors, including microbial translocation, monocyte activation, and endothelial dysfunction, have been described in other comorbidities, but have not been investigated in relation to pulmonary abnormalities in HIV. This study assessed the relationship of these pathologic processes to pulmonary function in HIV-infected and uninfected individuals and determined if relationships were unique to HIV.

designLongitudinal observational study.

methodsTotal 274 participants completed pulmonary function testing. Markers of inflammation (IL-6, IL-8, and TNFα), microbial translocation (lipopolysaccharide, sCD14), monocyte activation (sCD163, sCD14, and IL-2 receptor), and endothelial dysfunction (endothelin-1) were measured at baseline. Cross-sectional and longitudinal analyses were performed, adjusting for pertinent covariates.

resultsIn HIV-infected individuals, higher IL-6 and endothelin-1 associated with worse forced expiratory volume in one second (FEV1) percentage-predicted, and higher sCD163 associated with worse FEV1/forced vital capacity. IL-6, TNFα, lipopolysaccharide, sCD163, IL-2 receptor, and endothelin-1 associated with diffusing impairment. sCD163 and endothelin-1 interacted with HIV status in relationship to pulmonary function. In HIV-infected individuals only, baseline endothelin-1 was associated with lower FEV1, and sCD163 and endothelin-1 were associated with lower diffusing capacity during follow-up.

conclusionCirculating markers of HIV-associated humoral abnormalities are associated with airflow obstruction and diffusing impairment and baseline measures of monocyte activation and endothelial dysfunction associate with lower pulmonary function over time in HIV-infected persons. These findings suggest mechanisms of the disproportionate burden of chronic obstructive pulmonary disease in HIV-infected persons.

Indexed as

Antigens, CDCytokinesEndothelial CellsEndothelin-1HIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedMonocytesPulmonary Disease, Chronic ObstructiveRespiratory Function TestsAntigens, CDCytokinesEndothelin-1

Identifiers

PMID26990629
PMCPMC4948184
OpenAlexW2299226769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.